Personal information

Emails & domains

Verified email addresses

Websites & social links

Homepage

Countries

South Korea

Activities

Collapse all

Employment (2)

Theragen Bio: Seongnam, KR

2021-08-02 to present
Employment
Source: Self-asserted source
Sejin Oh

Yonsei University College of Medicine: Seodaemun-gu, Seoul, KR

2015-09-01 to 2021-08-31 (Severance Biomedical Science Institute)
Employment
Source: Self-asserted source
Sejin Oh

Education and qualifications (1)

Dongguk University: Jung-gu, Seoul, KR

2009-03-02 to 2015-08-19 | BS (Life science & Biomedical engineering)
Education
Source: Self-asserted source
Sejin Oh

Professional activities (1)

K-genome: Seoul, KR

2019-11 | 2019 UCC contest: Biological big data analysis
Distinction
Source: Self-asserted source
Sejin Oh

Works (7)

Selective cytotoxicity of a novel mitochondrial complex I inhibitor, YK-135, against EMT-subtype gastric cancer cell lines due to impaired glycolytic capacity

BMB Reports
2022-12-31 | Journal article
DOI: 10.5483/bmbrep.2022.55.12.150
Part of ISSN: 1976-670X
Contributors: Yeojin Sung; Seungbin Cha; Sang Bum Kim; Hakhyun Kim; Seonghwi Choi; Sejin Oh; Minseo Kim; Yunji Lee; Gino Kwon; Jooyoung Lee et al.
Source: Self-asserted source
Sejin Oh

WNK3 inhibition elicits antitumor immunity by suppressing PD-L1 expression on tumor cells and activating T-cell function.

Experimental & molecular medicine
2022-11 | Journal article
DOI: 10.1038/s12276-022-00876-z
PMID: 36357569
Contributors: Yoon HJ; Kim GC; Oh S; Kim H; Kim YK; Lee Y; Kim MS; Kwon G; Ok YS; Kwon HK et al.
Source: Self-asserted source
Sejin Oh via Europe PubMed Central

Multi-layered proteogenomic analysis unravels cancer metastasis directed by MMP-2 and focal adhesion kinase signaling

Scientific Reports
2021-08-24 | Journal article
Source: Self-asserted source
Sejin Oh

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities

Nature Communications
2020-07-03 | Journal article
DOI: 10.1038/s41467-020-17139-y
Contributors: Sejin Oh; Jeonghun Yeom; Hee Jin Cho; Ju-Hwa Kim; Seon-Jin Yoon; Hakhyun Kim; Jason K. Sa; Shinyeong Ju; Hwanho Lee; Myung Joon Oh et al.
Source: check_circle
Crossref

Pharmacogenomic Analysis Reveals CCNA2 as a Predictive Biomarker of Sensitivity to Polo-Like Kinase I Inhibitor in Gastric Cancer

Cancers
2020-05-30 | Journal article
DOI: 10.3390/cancers12061418
Contributors: Yunji Lee; Chae Eun Lee; Sejin Oh; Hakhyun Kim; Jooyoung Lee; Sang Bum Kim; Hyun Seok Kim
Source: check_circle
Crossref

Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT

Gastroenterology
2018-09 | Journal article
DOI: 10.1053/j.gastro.2018.05.024
Part of ISSN: 0016-5085
Source: Self-asserted source
Sejin Oh

Emerging power of proteomics for delineation of intrinsic tumor subtypes and resistance mechanisms to anti-cancer therapies.

Expert review of proteomics
2016-09-16 | Journal article
DOI: 10.1080/14789450.2016.1233063
PMID: 27599289
Source: Self-asserted source
Sejin Oh
How many people are using ORCID?